ArticleFrontiers in medicine2025
A prognostic framework integrating endoplasmic reticulum stress dynamics reveals clinical stratification and differential prognostic attributes in osteosarcoma patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endoplasmic reticulum (ER) stress is recognized as a pivotal factor in the initiation and advancement of osteosarcoma; however, its implications for patient prognosis remain poorly understood. Methods: Our objective was to elucidate the prognostic implications and immune infiltration patterns associated with endoplasmic reticulum (ER) stress in osteosarcoma patients through the synthesis of existing osteosarcoma datasets and the application of advanced bioinformatics methodologies. Results: Our findings elucidate distinct and heterogeneous expression patterns of endoplasmic reticulum (ER) stress-related genes in osteosarcoma, contrasting sharply with those identified in osteocytes and mesenchymal stem cells. We developed a robust ER stress model comprising ten ER stress-associated genes specifically tailored for osteosarcoma patients. This model was constructed utilizing univariate analysis and least absolute shrinkage and selection operator (LASSO) regression techniques. The predictive robustness and applicability of the model were ascertained through receiver operating characteristic (ROC) curve analysis and validation against external datasets. Notably, stratification based on the model demonstrated statistically significant correlations with patient survival outcomes. Furthermore, protein-protein interaction network analyses unveiled several pathways pertinent to tumor biology and immune responses. Intriguingly, the low-risk cohort exhibited enhanced immune infiltration, with the density of Th1 cell infiltration showing a positive correlation with increased patient risk, thereby highlighting its potential as a prognostic biomarker. Differential gene clustering analysis further underscored the critical role of ER stress models in prognostic predictions. Finally, our study identifies the IL4 signaling pathway is significantly associated with a good prognosis ( Conclusion: Our findings suggest that evaluating endoplasmic reticulum stress levels and associated models in osteosarcoma patients could inform clinical interventions and enhance patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.